DaVita: Nocturnal In-center HD Beats Standard HD
A study of 2,747 patients treated at all of the 176 DaVita in-center nocturnal HD (INHD) programs in 2017 and 2018 found an array of benefits. INHD patients had higher solute clearance, gentler water removal—for less organ stunning, higher serum albumin, and less hospitalization than those on standard HD, revealed a poster at ASN Kidney Week.
Read the full article » | Posted 11-16-2019
Related Articles
- ETC Model Structure Did Not Move the Needle on Home Dialysis with Social Risk Factors Posted 07-12-2024
- FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death Posted 05-09-2024
- New Partnership Will Bring Tablo to 33 States Where US Renal Care has Clinics Posted 05-09-2024
- Tablo-maker Outset Joined the ANNA’s Partnership Advisory Council Posted 05-09-2024